Fairfax India Holdings Corporation (OTCMKTS:FFXDF – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 18,521 shares, a decrease of 47.3% from the September 30th total of 35,139 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 45,519 shares, the days-to-cover ratio is currently 0.4 days.
Fairfax India Stock Up 0.5%
OTCMKTS FFXDF traded up $0.09 during trading on Monday, hitting $18.02. 7,846 shares of the company traded hands, compared to its average volume of 32,856. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.17. The business has a fifty day simple moving average of $17.98 and a 200 day simple moving average of $17.86. The company has a market capitalization of $2.43 billion, a P/E ratio of 12.09 and a beta of 0.86. Fairfax India has a 12 month low of $15.46 and a 12 month high of $20.49.
Fairfax India (OTCMKTS:FFXDF – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $1.34. The business had revenue of ($111.49) million for the quarter, compared to analyst estimates of $3.72 million.
About Fairfax India
Fairfax India Holdings Corporation is an investment holding company focused on acquiring and managing long-term investments in India and India-related businesses. The company seeks opportunities across a range of sectors, including financial services, infrastructure, industrial operations, consumer products and other businesses that may benefit from India’s economic development.
Fairfax India has invested in both publicly traded and private companies, with its portfolio historically including interests in businesses such as Bangalore International Airport Limited and other Indian financial, industrial and infrastructure enterprises.
Further Reading
- Five stocks we like better than Fairfax India
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Fairfax India Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fairfax India and related companies with MarketBeat.com's FREE daily email newsletter.
